Heme vs non-heme iron: what the difference actually means

The common claim that heme iron is “better” rests on a single fact: it absorbs faster. Heme iron — found in animal flesh — enters the bloodstream at 15–35%. Non-heme iron — found in plants, legumes, and fortified grains — absorbs at 2–20% depending on dietary context and the individual’s iron status (NIH ODS; NIH StatPearls, 2024). That difference is real. What it means is something else entirely.

Absorption rate and biological safety are not the same thing. The body has a sophisticated gate for non-heme iron and a much weaker one for heme iron. When you understand how those gates work, the picture inverts: non-heme iron’s variable absorption is the regulatory feature, not the design flaw.

The quick version

	Heme iron	Non-heme iron
Sources	Red meat, organ meat, poultry, fish	Legumes, seeds, leafy greens, fortified grains
Absorption range	15–35%	2–20%
Primary transporter	HCP1 (Heme Carrier Protein 1)	DMT1 (Divalent Metal Transporter 1)
Regulated by hepcidin?	Partially	Tightly
Affected by vitamin C?	No	Yes — substantially
Affected by phytates?	No	Yes — reducible by food preparation

In long-term plant-based eaters, physiological adaptation narrows the absorption gap further. A 2025 controlled trial measured a mean non-heme iron AUC of 1002.8 ± 143.9 µmol/L/h in vegans vs 853 ± 268.2 µmol/L/h in omnivores — roughly 18% higher, on an equivalent iron load (López-Moreno et al., 2025).

Two doors into the same cell

Heme and non-heme iron enter duodenal enterocytes through separate pathways, and this matters for everything downstream.

Heme iron travels intact from food to the enterocyte. Inside the small intestine, it is recognized by Heme Carrier Protein 1 (HCP1), carried through the apical membrane, and then catabolised by heme oxygenase to release Fe²⁺ into the cellular iron pool. The porphyrin ring structure that makes iron “heme” shields it from most of the gut environment — it doesn’t bind to phytates or polyphenols, and ascorbic acid has no effect on its uptake (Przybyszewska & Żekanowska, 2014; West & Oates, 2008).

Non-heme iron arrives as Fe³⁺ (ferric iron) and cannot cross the apical membrane in that form. The enzyme duodenal cytochrome B (DcytB) first reduces it to Fe²⁺ (ferrous iron), which then enters via DMT1. This extra step is where enhancers and inhibitors act: ascorbic acid accelerates the Fe³⁺ → Fe²⁺ reduction and chelates the iron to keep it soluble; phytates and polyphenols compete to form insoluble complexes that prevent DMT1 entry (Piskin et al., 2022; Przybyszewska & Żekanowska, 2014).

Why regulated absorption is the advantage

Once iron is inside the enterocyte, it either crosses the basolateral membrane into systemic circulation via ferroportin, or it stays in the cell and is lost when the enterocyte turns over every few days.

The hormone hepcidin controls this gate. When iron stores are full, the liver secretes hepcidin, which binds ferroportin and triggers its degradation — shutting the door on further iron export. When stores are low, hepcidin falls, ferroportin is expressed, and more iron crosses into the blood (Przybyszewska & Żekanowska, 2014; NIH ODS).

This feedback loop works cleanly for non-heme iron. It works only partially for heme iron. Heme’s route through HCP1 is less completely regulated by hepcidin, meaning heme iron continues to enter the bloodstream in amounts more proportional to intake than to need. In practical terms: when a plant-based eater’s iron stores are low, DMT1 up-regulates and absorption climbs substantially. When an omnivore eats a large heme-rich meal, the gate stays more open than it should.

What the population data show — and what they don’t

Epidemiological cohorts have found associations between heme iron intake and two conditions. In a dose–response meta-analysis of prospective cohorts, each additional 1 mg/day of heme iron was associated with approximately a 7% increase in coronary heart disease risk (pooled RR 1.07, 95% CI 1.01–1.14). No significant association was found for non-heme iron or total iron in the same analyses (Fang et al., 2015).

For colorectal cancer, a 2011 meta-analysis found each additional 1 mg/day of dietary heme iron associated with an ~11% increase in risk (summary RR 1.11, 95% CI 1.03–1.18; Bastide et al., 2011). The large EPIC cohort (n = 450,105, 14.2-year follow-up) found no statistically significant association between heme iron and colorectal cancer overall; non-heme iron was inversely associated with colorectal cancer risk in men in the same analysis (Aglago et al., 2023).

These findings are observational. No randomised controlled trial isolating heme iron at food-level doses has established causality. The associations could partly reflect other aspects of meat-heavy dietary patterns. They are suggestive, not definitive.

Similarly, excess supplemental non-heme iron at pharmacological doses (above roughly 45 mg elemental iron/day) can overwhelm the hepcidin/ferroportin gate and cause GI distress and elevated free-radical load. The regulatory advantage of non-heme iron applies at dietary intakes, not at therapeutic mega-doses.

Adaptation in plant-based eaters

The population-average absorption figures — 5–12% bioavailability for vegetarian diets — are calculated from people with average iron stores (NIH ODS). They understate what a long-term plant-based eater actually absorbs.

López-Moreno et al. (2025) administered an equivalent non-heme iron load to 27 participants (ages 18–30) divided into vegans and omnivores and measured serum iron area under the curve. Vegans showed significantly higher AUC (1002.8 ± 143.9 vs 853 ± 268.2 µmol/L/h). Multivariate regression tied the adaptation to lower baseline hepcidin levels — consistent with the mechanism: lower stores, lower hepcidin, more ferroportin expressed, more iron exported.

This does not mean every plant-based eater is protected. The study was small (n = 27), restricted to healthy adults aged 18–30, and cannot speak to older individuals, pregnant women, endurance athletes, or people who recently transitioned to a plant-based diet. Adaptation takes time and requires adequately low iron stores — neither guaranteed in all populations.

Practical guidance

• Pair high-iron plant foods with ascorbic acid. At least 30–50 mg of vitamin C per meal reduces Fe³⁺ to Fe²⁺ and chelates iron, overcoming phytate and polyphenol inhibition at practical food-pairing doses (Piskin et al., 2022). Half a bell pepper, a small glass of orange juice, or a handful of strawberries alongside a lentil dish is enough.

• Prioritise reliable sources. Legumes (lentils, chickpeas, black beans), pumpkin seeds, hemp seeds, and iron-fortified grains are more dependable than spinach, which contains oxalates that bind iron and reduce its bioavailability.

• Spread absorption across meals. Because the enterocyte turnover pool is finite, smaller, more frequent iron-containing meals outperform a single large one.

• Know your high-risk periods. Premenopausal women, pregnant women, adolescents, and endurance athletes face higher iron demands. Ferritin testing every 1–2 years is reasonable regardless of dietary pattern. A low-normal ferritin (under 30 ng/mL) is worth addressing before symptoms appear.

• The IOM 1.8× multiplier is a planning figure, not a verdict. The Institute of Medicine recommends plant-based eaters target roughly 1.8 times the standard RDA (~32 mg/day for premenopausal women) to account for lower average bioavailability (NIH ODS). For long-term plant-based eaters with demonstrable adaptive absorption, the practical gap may be smaller — but the elevated target remains a defensible precaution, especially for high-risk groups.

Common misconceptions

• “Heme iron is the gold standard — it absorbs better, full stop.” Higher absorption rate is not the same as a better biological outcome. Heme iron’s absorption partially bypasses the hepcidin/ferroportin regulatory axis, which is associated with excess iron accumulation and, in population studies, with elevated cardiovascular and colorectal cancer risk. More absorbed does not mean better absorbed.

• “If you’re plant-based, you only absorb a trickle of iron.” The 5–12% vegetarian bioavailability figure is a population average calculated on people with replete stores. For people with lower stores — the typical state in long-term plant-based eaters — DMT1 is up-regulated and absorption rises. A 2025 controlled trial measured roughly 18% higher non-heme iron AUC in vegans than omnivores on the same iron load (López-Moreno et al., 2025).

• “Spinach is one of the best iron sources.” Spinach contains meaningful iron by weight, but it also contains oxalates, which form insoluble iron complexes and dramatically reduce bioavailability. Lentils, chickpeas, pumpkin seeds, and fortified grains are more reliable delivery vehicles.

• “You can’t do much about poor non-heme absorption.” You can. Ascorbic acid at 30–50 mg per meal fully overcomes phytate inhibition under typical dietary conditions (Piskin et al., 2022). The pairing strategy is specific to non-heme iron — it has no effect on heme iron because the mechanism is different.

• “The 1.8× vegetarian RDA multiplier means plant-based eaters are inherently iron-deficient.” The multiplier is a conservative population-level planning figure derived from bioavailability modelling, not a clinical finding. Newer controlled data suggest long-term plant-based eaters adapt upward. Deficiency is a distinct clinical outcome requiring ferritin confirmation — not an automatic consequence of diet.

The punchline

The headline gap between heme and non-heme absorption closes substantially once you account for physiological adaptation, dietary context, and the regulatory consequences of bypassing the hepcidin gate. Non-heme iron’s variability is a feature of a tightly regulated system, not evidence of an inadequate nutrient.

For the full picture — including how iron status in plant-based eaters compares across life stages, which groups need closer monitoring, and how blood tests should be interpreted — see Iron and plant-based diets.